Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 153.20
+5.20 (3.51%)
At close: Sep 3, 2026
DSE:BXPHARMA Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, DSE:BXPHARMA stock has a consensus rating of "Strong Buy" and an average price target of ৳183.37. The average 1-year stock price forecast is 19.69% higher than the current stock price, while the lowest is ৳138.50 (-9.60%) and the highest is ৳258.60 (+68.80%).
Price Target: ৳183.37 (+19.69%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for DSE:BXPHARMA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Jul '25 | Oct '25 | Feb '26 | Mar '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 3 | 2 | 2 | 1 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 3 | 2 | 2 | 1 | 3 |
Financial Forecast
Revenue This Year
54.78B
from 49.12B
Increased by 11.53%
Revenue Next Year
60.95B
from 54.78B
Increased by 11.26%
EPS This Year
19.42
from 15.56
Increased by 24.81%
EPS Next Year
21.37
from 19.42
Increased by 10.02%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is BDT.